LIVE
NIFTY 5024,856.35+0.42%SENSEX81,501.36+0.38%BANK NIFTY52,786.20-0.12%NIFTY IT42,312.55+1.24%NIFTY PHARMA22,145.80+0.67%INDIA VIX12.85-3.24%USD/INR83.42+0.05%GOLD₹71,250+0.82%CRUDE$82.34-0.44%NIFTY MIDCAP57,234.80+0.73%NIFTY 5024,856.35+0.42%SENSEX81,501.36+0.38%BANK NIFTY52,786.20-0.12%NIFTY IT42,312.55+1.24%NIFTY PHARMA22,145.80+0.67%INDIA VIX12.85-3.24%USD/INR83.42+0.05%GOLD₹71,250+0.82%CRUDE$82.34-0.44%NIFTY MIDCAP57,234.80+0.73%
NSE Open

Niva Bupa Health Insurance

Mainboard
Insurance
65/100
AEX AI Score
+6
Grey Market
Price Band
₹74–78
Issue Size
₹2,200 Cr
Lot Size
192 shares
Min Investment
₹14,976
Open Date
7 Nov 2024
Close Date
11 Nov 2024
Listing Date
14 Nov 2024
Registrar
Link Intime India

Subscription Status

2.34x
QIB
1.12x
NII/HNI
1.45x
Retail
1.87x
Overall

Listing Performance

Issue Price
78
Listing Price
84.0
Listing Gain
+7.7%

Company Financials (FY24)

Revenue
₹5,124 Cr
PAT
₹-129 Cr
PAT Margin
-2.5%
ROE
-4.2%

About the Company

India's fastest growing standalone health insurer with strong brand. Loss-making at current scale, banking on market expansion. Expensive valuations compared to listed peers. Long-term story intact but short-term listing gains may be muted.

IPO Objectives

  • 1.Funding capital expenditure for expansion of operations
  • 2.Repayment or prepayment of certain borrowings availed
  • 3.Funding working capital requirements of the company
  • 4.General corporate purposes including inorganic growth
AEX AI — IPO Analysis
Cautious
Strengths
+Strong brand presence and market leadership
+Healthy revenue growth trajectory
+Diversified customer base with low concentration risk
Risks
Elevated valuation vs sector peers
Profitability improving but not stable yet
Competitive intensity increasing

Lead Managers

Morgan Stanley
Axis Capital
ICICI Securities

IPO Timeline

IPO Open
7 Nov
IPO Close
11 Nov
Allotment Date
12 Nov
Listing on NSE/BSE
14 Nov